Publications by authors named "Michael E Allison"

Article Synopsis
  • Five genetic variants have been linked to the progression of non-alcoholic fatty liver disease to more severe forms like NASH-fibrosis, with a noteworthy variant identified in the MTARC1 gene.
  • The study analyzed metabolomics data from over 18,000 participants across two major studies, focusing on how these genetic variants affect metabolism by measuring levels of 1,449 metabolites.
  • Each identified variant showed a unique metabolite profile primarily impacting lipid metabolism, with specific associations, such as the MTARC1 variant correlating with increased sphingomyelin levels, suggesting different biochemical pathways linked to each variant.
View Article and Find Full Text PDF

Aims: Liver pathology is a challenging subspeciality, with histopathologists frequently seeking specialist opinions. This study aims to determine the impact of specialist reviews on the final diagnosis and patient management.

Methods And Results: Agreement with the initial reporting centre in the histopathological diagnosis of 1265 liver biopsies was determined.

View Article and Find Full Text PDF

Ischemia/reperfusion injury (IRI) that develops after liver implantation may prejudice long-term graft survival, but it remains poorly understood. Here we correlate the severity of IRIs that were determined by histological grading of time-zero biopsies sampled after graft revascularization with patient and graft outcomes. Time-zero biopsies of 476 liver transplants performed at our center between 2000 and 2010 were graded as follows: nil (10.

View Article and Find Full Text PDF

Non-alcoholic fatty liver disease (NAFLD) is an increasingly common condition, strongly associated with the metabolic syndrome, that can lead to progressive hepatic fibrosis, cirrhosis and hepatic failure. Subtle inter-patient genetic variation and environmental factors combine to determine variation in disease progression. A common non-synonymous polymorphism in TM6SF2 (rs58542926 c.

View Article and Find Full Text PDF

Background: The term 'zero tolerance' has recently been applied to healthcare-associated infections, implying that such events are always preventable. This may not be the case for healthcare-associated infections such as methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia.

Methods: We combined information from an epidemiological investigation and bacterial whole-genome sequencing to evaluate a cluster of five MRSA bacteraemia episodes in four patients in a specialist hepatology unit.

View Article and Find Full Text PDF

Objectives: Conventional imaging techniques are insensitive to liver fibrosis. This study assesses the diagnostic accuracy of MR elastography (MRE) stiffness values and the ratio of phosphomonoesters (PME)/phosphodiesters (PDE) measured using (31)P spectroscopy against histological fibrosis staging.

Methods: The local research ethics committee approved this prospective, blinded study.

View Article and Find Full Text PDF

Renal impairment is common in patients after liver transplantation and is attributable in large part to the use of calcineurin inhibitor (CNI)-based immunosuppression. We sought to determine whether conversion to sirolimus-based immunosuppression was associated with improved renal function. In a single-center, randomized, controlled trial, 30 patients at least 6 months post liver transplantation were randomized to remain on CNI-based immunosuppression or to switch to sirolimus-based immunosuppression.

View Article and Find Full Text PDF
Article Synopsis
  • * Out of 186 liver transplant patients on sirolimus, 4 (2.2%) developed pneumonitis, presenting symptoms included shortness of breath, cough, and fatigue, and diagnosis involved lung biopsies and imaging.
  • * All affected patients recovered fully after stopping sirolimus therapy, highlighting the importance of early recognition of respiratory symptoms associated with sirolimus use in liver transplant recipients.
View Article and Find Full Text PDF
Fatty liver.

Hosp Med

October 2004

Fatty liver is increasingly becoming more problematic from a clinical perspective. This article describes fatty liver and its clinical presentation. The current understanding of processes underlying fatty liver is reviewed, as well as the evidence for therapeutic options.

View Article and Find Full Text PDF